妊娠合并重型肝炎的临床治疗  

Clinical Treatment of Pregnancy with Severe Hepatitis

作　　者：龚宇 杨林 徐小凤 黎锐勤 罗虹 徐晓 

机构地区：[1]东莞市石龙博爱医院妇产科,广东东莞523022

出　　处：《黑龙江医学》2013年第11期1058-1059,共2页Heilongjiang Medical Journal

摘　　要：目的探讨妊娠合并重型肝炎的临床治疗方法与效果。方法将我院收治的90例妊娠合并重型肝炎患者,根据药物应用的不同分为治疗组与对照组各45例,在一般治疗基础上,治疗组给予肝泰乐加谷胱甘肽治疗。结果治疗组治疗前后AST、ALT和ALB对比有明显差异(P<0.05),而对照组变化不大(P>0.05)。治疗组的总有效率(95.6%)明显高于对照组(71.1%),差异具有统计学意义(P<0.05)。结论妊娠合并重型肝炎以慢性乙型重型肝炎为主,肝泰乐加谷胱甘肽辅助治疗能取得比较好的效果。Objective To investigate the clinical treatment effects of pregnancy with severe hepatitis. Methods 90 cases with severe hepatitis during pregnancy based on different drug application were divided into the treatment group and the control group. All cases were given the general treatment,and the treatment group were given the Glucurolactone + glutathione treatment. Results Before and after treatment,the AST,ALT and ALB contrast had significant difference( P < 0. 05) in the treatment,and it had little change in the control group( P >0. 05). The total effective rate of the treatment group( 95. 6%) was significantly higher than that in the control group( 71. 1%)( P <0. 05). There was statistical meaning between the two groups. Conclusion Pregnancy with severe hepatitis mainly lies in the chronic severe hepatitis B. Glucurolactone + glutathione treatment will achieve better results.

关 键 词：妊娠合并重型肝炎 肝泰乐 谷胱甘肽 

分 类 号：R714.2[医药卫生—妇产科学]